FY2009 Revenue of $146.9 Million, Adjusted EBITDA of $14.4 Million
Continued Improvement in Revenue, Operating Income and Profit Performance
PLYMOUTH MEETING, Pa., March 16 /PRNewswire-Asia/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company") today announced financial results for the fourth quarter and fiscal year ended December 31, 2009.
Fourth Quarter 2009 Financial Highlights:
-- Revenue increased to $41.5 million, from $36.6 million in the fourth
quarter of 2008;
-- Gross profit increased 21% to $23.3 million, from $19.2 million in the
fourth quarter of 2008;
-- Gross margin increased to 56.1% from 52.4% in the prior year period;
-- Operating income increased to $4.0 million from $1.8 million in the
prior year period;
-- Adjusted EBITDA, as defined below, was $5.5 million for the quarter, up
69% on a year over year basis.
Full Year 2009 Financial Highlights:
-- Revenue increased 28% to $146.9 million, from $114.9 million in 2008;
-- Gross profit increased 29% to $74.0 million, from $57.3 million in 2008;
-- Gross margin increased to 50.4% from 49.9% on a year over year basis;
-- Operating income increased to $8.4 million from $3.7 million in the
prior year period;
-- Adjusted EBITDA, as defined below, was $14.4 million for the year 2009,
up 36% on a year over year basis.
David Gao, Chief Executive Officer of BMP Sunstone, stated, "We achieved a record year in 2009 and we are proud of the progress we have made across our operating segments, all of which were profitable on an operating basis by the end of the year. Revenue growth and operating income performance were particularly strong in the back part of the year. As we enter 2010, we are focused on driving greater-than-industry growth with our diverse product portfolio, established distribution in many of China's most important healthcare markets, and leading brands in pediatrics and women's health."
Fourth Quarter 2009 Financial Results
Revenue in the fourth quarter of 2009 increased 13.4% to $41.5 million from $36.6 million in the fourth quarter of 2008, reflecting increased demand for the Company's manufactured products and licensed products. The former increased by 20.7% to $25.6 million and the latter by 34.6% to $2.1 million, reflecting sales and marketing efforts of Propess, Anpo, Ferriprox and Galake compared to the prior year. Revenue from distribution was roughly flat on a year over year basis at $13.9 million, reflecting continued sales performance at Rongheng and from Wanwei's major products.
Gross profit in the fourth quarter of 2009 increased 21.3% to $23.3 million from $19.2 million in the fourth quarter of 2008. Gross margin was 56.1% compared to 52.4% in the prior year period. Gross margin performance reflects increased sales of higher margin products from manufactured products and licensed products, which carried margins of 80.6% and 62.3% respectively.
The Company's operating income improved significantly year over year to $4.0 million in the fourth quarter of 2009 compared to $1.8 million in the fourth quarter of 2008. Non-GAAP operating income was $5.5 million in the fourth quarter of 2009, compared to $3.5 million in the prior year period, further highlighting the significant increase in revenues contributed from acquired businesses in the year over year period.
Non-GAAP net income was $3.6 million, or $0.07 per diluted share, compared to $4.1 million, or $0.10 per diluted share, in the fourth quarter of 2008. On a GAAP basis, the Company reported net income of $2.0 million, or $0.04 per diluted share, compared to $1.4 million, or $0.03 per diluted share, in the fourth quarter of 2008. During the fourth quarter of 2008, the Company had a $1.4 million tax benefit reflecting the reduction in tax rate from 25% to 15% for 2008, 2009 and 2010, as a result of receiving hi-tech tax status.
Non-GAAP net income and earnings per share exclude stock based compensation expense, amortization related to acquisitions, amortization of debt discount and issuance cost, loss on early extinguishment of debt and gain on the embedded derivative value on convertible notes. Adjusted EBITDA is a non-GAAP measure which provides earnings before interest, taxes, depreciation and amortization and excludes loss on early extinguishment of debt and gain on the embedded derivative value on convertible notes. Please refer to the financial tables provided in this news release for a reconciliation of GAAP results to non-GAAP results for the three and twelve month periods ended December 31, 2008 and 2009.
Full Year 2009 Financial Results
Revenue in the fiscal year 2009 increased 27.9% to $146.9 million from $114.9 million in 2008, reflecting approximately $84.0 million in revenue from Sunstone, which was up 27.8% on a year over year basis. Revenue from distribution increased 27.7% to $55.8 million from $43.7 million in the year 2008. Revenue from licensed products increased 30.0% to $7.0 million from $5.4 million in 2008, reflecting sales and marketing efforts of Propess, Anpo, Ferriprox and Galake, compared to the prior year.
Gross profit increased 29.1% to $74.0 million from $57.3 million in 2008, and gross margin for the year was 50.4% compared to 49.9% in the prior year. Higher gross profit largely reflects revenue from the sales of the Company's manufactured products, which yielded a gross margin of 77.8% in 2009.
The Company's operating income improved significantly year over year to $8.4 million compared to $3.7 million in 2008. Operating expenses of $65.6 million reflect a 20.5% increase in sales and marketing expenses and a 28.4% increase in general and administrative expenses, commensurate with year over year growth in the business. Non-GAAP operating income reached $14.3 million in 2009 compared to $10.5 million in the prior year, further highlighting the significant increase in revenues contributed from acquired businesses in the year over year period.
Non-GAAP net income was $8.2 million, or $0.17 per diluted share, in 2009 compared to $7.2 million, or $0.18 per diluted share, in 2008. On a GAAP basis, the Company's net loss improved to $2.0 million, a net loss of $0.05 per diluted share, from a net loss of $3.4 million, a net loss of $0.09 per diluted share, in 2008.
Balance Sheet
As of December 31, 2009, the Company had cash and cash equivalents of $21.5 million and notes receivable of $17.5 million, totaling $39.1 million. Notes receivables from customers for the settlement of trade receivable balances are guaranteed by established banks in China and have maturities of six months or less.
Financial Guidance
In 2010, revenue is anticipated to grow from $146.9 million for 2009 to $160 million - $170 million.
The Company expects adjusted EBITDA for the full year 2010 to reach $16 million - $17 million.
The Company expects non-GAAP net income for the full year 2010 to reach $9 million - $10 million.
Yanping Zhao Promoted to Chief Operating Officer
Today the Company announced Yanping Zhao has been promoted to Chief Operating Officer of BMP Sunstone. Ms. Zhao has served as the Corporate Vice President of BMP Sunstone since October 2007. Prior to joining BMP Sunstone in 2007, Ms. Zhao held various senior positions with Sino Biopharmaceutical Ltd. Ms Zhao has successfully grown BMP China's operations and has played a critical role helping the Company achieve operational excellence at all business units as well as in the successful transition at Sunstone.
Conference Call
The Company will hold a conference call at 5:00 pm ET on March 15, 2010 to discuss its results. Listeners may access the call by dialing 1-888-679-8035 or 1-617-213-4848 for international callers, access code: 60008597. Pre-registration and a webcast will be available through the Company's website at http://www.bmpsunstone.com . A replay of the call will be accessible through March 22, 2010 by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 50833260.
About BMP Sunstone Corporation
BMP Sunstone Corporation ("BMP Sunstone" or the "Company") is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Through Sunstone Pharmaceutical Co. Ltd., the Company manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold throughout the country in approximately 120,000 pharmacies. The Company also markets a portfolio of products under exclusive multi-year licenses into China, primarily focused on women's health and pediatrics, as well as provides pharmaceutical distribution services through subsidiaries in Beijing and Shanghai. BMP Sunstone's main office is in Beijing, with a U.S. office in Plymouth Meeting, PA. For more information, please visit http://www.bmpsunstone.com .
Safe Harbor Statement
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts, including but not limited to statements about the Company's strategic and market penetration strategies and the potential effects of the listing of the Company's products on China's National (Medical) Insurance Catalog. These statements are subject to uncertainties and risks including, but not limited to, operating performance, general financial, economic, and political conditions affecting the biotechnology and pharmaceutical industries and the Chinese pharmaceutical market, the ability to timely manufacture and distribute the Company's products and other risks contained in reports filed by the Company with the Securities and Exchange Commission. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
BMP Sunstone Corporation and Subsidiaries
Condensed Consolidated Statements of Operation
($ amounts, except per share amounts in thousands)
For the Three
Months Ended For the Year Ended
December 31, December 31,
2009 2008 2009 2008
Revenues:
Third parties $41,416 $35,267 $142,417 $108,246
Related parties 81 1,370 4,451 6,621
Total Revenues 41,497 36,637 146,868 114,867
Cost of Goods Sold 18,216 17,437 72,859 57,557
Gross Profit 23,281 19,200 74,009 57,310
Sales and Marketing Expenses 14,156 13,415 47,778 39,666
General and Administration Expenses 5,089 4,012 17,844 13,898
Total Operating Expenses 19,245 17,427 65,622 53,564
Profit From Operations 4,036 1,773 8,387 3,746
Other Income (Expense):
Interest Income 65 2 225 70
Interest Expense (1,061) (1,531) (4,430) (6,301)
Debt Issuance Cost Amortization (120) (210) (446) (840)
Equity Method Investment Income (164) -- 25 675
Loss on Early Extinguishment of Debt -- -- (4,573) --
Gain(Loss) on Derivatives -- -- 1,204 --
Total Other Income (Expense) (1,280) (1,739) (7,995) (6,396)
Profit (Loss) Before Provision For
Income Taxes 2,756 34 392 (2,650)
Provision For Income Taxes 809 (1,406) 2,392 792
Net Profit (Loss) $1,947 $1,440 $(2,000) $(3,442)
Less: Net Loss Attributable to the
Noncontrolling Interest 61 -- 96 --
Net Profit (Loss) Attributable to BMP
Sunstone Corporation $2,008 $1,440 $(1,904) $(3,442)
Basic Profit (Loss) Per Share $0.05 $0.04 $(0.05) $(0.09)
Fully-Diluted Profit (Loss) Per
Share $0.04 $0.03 $(0.05) $(0.09)
Basic Weighted-average Shares
Outstanding 41,716 40,185 41,398 38,617
Fully Diluted Weighted-average
Shares Outstanding 50,676 41,408 48,633 39,841
BMP Sunstone Corporation and Subsidiaries
Condensed Consolidated Statements of Operation
($ amounts, except per share amounts in thousands)
Non GAAP
For the Three
Months Ended For the Year Ended
December 31, December 31,
2009 2008 2009 2008
Revenues:
Third parties $41,416 $35,267 $142,418 $108,246
Related parties 81 1,370 4,451 6,621
Total Revenues 41,497 36,637 146,869 114,867
Cost of Goods Sold 18,101 17,308 72,400 56,543
Gross Profit 23,396 19,329 74,469 58,324
Sales and Marketing Expenses 13,409 12,532 44,799 36,607
General and Administration Expenses 4,470 3,342 15,360 11,194
Total Operating Expenses 17,879 15,874 60,159 47,801
Profit From Operations 5,517 3,455 14,310 10,523
Other Income (Expense):
Interest Income 21 2 100 70
Interest Expense (1,069) (765) (3,988) (3,234)
Debt Issuance Cost Amortization -- -- -- --
Equity Method Investment Income (164) -- 25 675
Loss on Early Extinguishment of Debt -- -- -- --
Gain on Derivatives -- -- -- --
Total Other Income (Expense) (1,212) (763) (3,863) (2,489)
Profit Before Provision For Income
Taxes 4,305 2,692 10,447 8,034
Provision For Income Taxes 809 (1,406) 2,392 792
Net Profit $3,496 $4,098 $8,055 $7,242
Less: Net Loss Attributable to the
Noncontrolling Interest 61 -- 96 --
Net Profit Attributable to BMP
Sunstone Corporation 3,557 4,098 8,151 7,242
Basic Profit Per Share $0.08 $0.10 $0.20 $0.19
Fully Diluted Profit Per Share $0.07 $0.10 $0.17 $0.18
Basic Weighted-average Shares
Outstanding 41,559 40,185 41,398 38,617
Fully Diluted Weighted-average
Shares Outstanding 50,676 41,408 48,863 39,841
BMP Sunstone Corporation and Subsidiaries
Condensed Consolidated Balance Sheets
($ amounts in thousands)
December 31, December 31,
2009 2008
Assets
Current Assets:
Cash and Cash Equivalents $21,544 $15,740
Restricted Cash 1,125 1,150
Notes Receivable 17,541 15,797
Accounts Receivable, net of allowance
for doubtful accounts of $481 and
$127 37,752 30,897
Inventory, net of allowance for
obsolescence of $98 and $0 9,811 10,184
Due from Related Party -- 1,834
Receivable from Alliance Unichem 7,550 --
Other Receivables 3,648 2,168
VAT Receivable 1,093 921
Prepaid Expenses and Other Current
Assets 6,322 6,247
Total Current Assets 106,386 84,938
Property and Equipment, net 30,967 22,840
Investment in Alliance BMP Limited -- 15,093
Investment in Shengda 2,950 --
Investments, at Cost 146 146
Goodwill 70,033 69,866
Other Assets 405 875
Land Use Rights, net of accumulated
amortization 2,860 2,002
Intangible Assets, net of accumulated
amortization 38,508 41,891
Total Assets $252,255 $237,651
Liabilities and Equity
Current Liabilities:
Notes Payable and Bank Borrowings,
net of debt discounts $6,406 $33,591
Accounts Payable 24,465 27,482
Due to Related Parties 1,437 4,361
Deferred Revenues 208 128
Accrued Expenses 18,478 14,601
Total Current Liabilities 50,994 80,163
Long-Term Debt, including debt
premium 36,749 --
Deferred Taxes 9,097 9,856
Total Liabilities 96,840 90,019
Commitment and Contingencies -- --
Equity:
Common Stock, $.001 Par Value;
75,000,000 and 50,000,000 Shares;
41,931,987 and 40,246,410 Shares
Issued and Outstanding as of
December 31, 2009 and December 31,
2008, respectively 42 40
Additional Paid in Capital 168,772 160,864
Common Stock Warrants 8,621 9,049
Accumulated Deficit (32,946) (31,042)
Accumulated Other Comprehensive
Income 9,486 8,721
Total BMP Sunstone Corporation
Stockholders' Equity 153,975 147,632
Noncontrolling Interest 1,440 --
Total Liabilities and Equity $252,255 $237,651
BMP Sunstone Corporation and Subsidiaries
Non GAAP Reconciliations
$( amounts, except per share in thousands)
Three Months Ended Year Ended
December 31, December 31,
2009 2008 2009 2008
GAAP Gross Profit $23,281 19,200 $74,009 $57,310
Amortization Related to Acquisition 115 129 460 1,014
Non GAAP Gross Profit $23,396 $19,329 $74,469 $58,324
Three Months Ended Year Ended
December 31, December 31,
2009 2008 2009 2008
GAAP Operating Income $4,036 $1,773 $8,387 $3,746
Stock Based Compensation 596 622 2,380 2,438
Amortization Related to Acquisitions 885 1,060 3,543 4,339
Non GAAP Operating Income $5,517 $3,455 $14,310 $10,523
Three Months Ended Year Ended
December 31, December 31,
(all amounts in $000) 2009 2008 2009 2008
GAAP Net Income (Loss) $2,008 $1,440 $(1,904) $(3,442)
GAAP EPS $0.05 $0.03 $(0.05) $(0.09)
Stock Based Compensation 596 622 2,380 2,438
Debt Discount and Premium Amortization
and Issuance Cost 68 976 763 3,907
Amortization Related to Acquisitions 885 1,060 3,543 4,339
Loss on Early Extinguishment of Debt -- -- 4,573 --
Gain (Loss) on Derivatives -- -- (1,204) --
Non GAAP Net Income $3,557 $4,098 $8,151 $7,242
Non GAAP EPS $0.07 $0.10 $0.17 $0.18
BMP Sunstone Corporation and Subsidiaries
Adjusted EBITDA Reconciliation
$(amounts in thousands)
For the Three
Months Ended For the Year Ended
December 31, December 31,
(all amounts in $000) 2009 2008 2009 2008
Net Income (Loss) $2,008 $1,440 $(1,904) $(3,442)
Net Loss Reconciliation to Adjusted
EBITDA:
Interest expense, net 996 763 3,837 3,164
Income taxes 809 (1,406) 2,392 792
Depreciation 692 418 2,437 1,842
Amortization of intangibles and fair
value of inventory increase 885 1,042 3,543 4,339
Loss on Early Extinguishment of Debt -- -- 4,573 --
Gain (Loss) on derivatives -- -- (1,204) --
Amortization of debt discount and
premium and debt issuance costs 68 976 763 3,907
ADJUSTED EBITDA $5,458 $3,233 $14,437 $10,602
